Clinical and pathogenetic substantiation of the use of Wobenzim in the complex treatment of generalized periodontitis.

The purpose of this study was to determine the efficacy of using Wobenzim as a general therapy in the complex treatment of generalized periodontitis. 61 patients, I-II degree of severity, with tooth safety in an amount of at least 90%, without concomitant general pathology requiring treatment for th...

Full description

Bibliographic Details
Main Author: I. S. Mashchenko
Other Involved Persons: T. O. Kucherenko
Format: electronic Article
Language:English
Russian
Ukrainian
Physical Description:Online-Ressource
DOI:10.26641/2307-0404.2018.2.133947
QR Code: Show QR Code
LEADER 02609nma a2200289 c 4500
001 DOAJ031709664
003 DE-601
005 20191101072924.0
007 cr uuu---uuuuu
008 180629s2018 000 0 eng d
024 7 |a 10.26641/2307-0404.2018.2.133947  |2 doi 
035 |a (DE-599)DOAJ2bfc84e201c94dc5bd7900e402d305ef 
040 |b ger  |c GBVCP 
041 0 |a eng  |a rus  |a ukr 
100 0 |a I. S. Mashchenko 
245 1 0 |a Clinical and pathogenetic substantiation of the use of Wobenzim in the complex treatment of generalized periodontitis.  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a The purpose of this study was to determine the efficacy of using Wobenzim as a general therapy in the complex treatment of generalized periodontitis. 61 patients, I-II degree of severity, with tooth safety in an amount of at least 90%, without concomitant general pathology requiring treatment for the current time were examined. Comparative effectiveness of treatment was studied in 2 groups similar in all clinical indices. The main (31 people) patients, along with the symptomatic treatment received Wobenzim; control (30 people) - polytherapy (immunocorrecting, antioxidant, antimicrobial agents). As a result of the generally accepted clinical, paraclinical, immunological and biochemical studies conducted during the treatment and at long-term follow-up, it was found that the use of systemic enzyme therapy in this category of patients ensures rapid regression of the main clinical symptoms (on days 6-7), elimination of pathogenetic links of the disease more than in 90% of treated patients and the onset of remission for at least 6-12 months. It is characteristic that during the monotherapy with Wobenzim, positive results of treatment of generalized periodontitis were achieved, similar to those with the use of complex standard therapy, including administration of a number of medications with targeted action on pathogenesis mechanisms of the disease. From the position of evidence-based medicine, the expediency of replacing a broad arsenal of medicines in the complex treatment of generalized periodontitis with certain pharmacological preparations with a systemic effect is justified. 
700 0 |a T. O. Kucherenko 
773 0 8 |i In  |g  (01.06.2018) 
856 4 0 |u http://dx.doi.org/10.26641/2307-0404.2018.2.133947 
856 4 0 |y DOAJ  |u https://doaj.org/article/2bfc84e201c94dc5bd7900e402d305ef 
856 4 0 |u http://journals.uran.ua/index.php/2307-0404/article/view/133947 
856 4 0 |u https://doaj.org/toc/2307-0404 
912 |a GBV_DOAJ 
951 |a AR 
952 |j 2018  |b 01  |c 06